DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. DexCom, Inc. also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet’s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

University of Iowa Hospitals and Clinics partners with the University of Iowa Roy J. and Lucille A. Carver College of Medicine and the University of Iowa Physicians group practice organization to make up the University of Iowa Health Care network. The organization provides residents of the Hawkeye State with an acute care hospital serving a variety of inpatient and outpatient needs, including more than 200 health care specialties. The facility also houses the Children's Hospital of Iowa and the Holden Comprehensive Cancer Center. As an teaching facility, it also houses 20 academic departments. The health care system, founded in 1898, has some 680 beds.

South Shore Hospital, a nearly 300-bed regional provider of acute, outpatient, home health, and hospice care for residents of southeastern Massachusetts. The not-for-profit hospital, founded in 1922, has a medical staff of more than 800 physicians and other health care providers. Specialized services include cancer care, emergency medicine, home health, and pediatrics.

TechHealth provides a network that allows claims handlers to direct referrals, view the status of claims, examine reports, and complete other medical tasks online. Its proprietary systems manage patient information and connect to insurance companies, health care providers, and state agencies. The company's core offerings manage diagnostic imaging, home health care, and physical therapy services. TechHealth also coordinates related services, such as appointment scheduling, medical equipment, pharmacy needs, transportation, specialty catastrophic care, workers' compensation, home modification, and translational services for patients. TechHealth was founded in 1999.

Amedisys, Inc. is the nation's leading health care company focused on bringing home the continuum of care. Each day Amedisys delivers personalized health care services to more than 35,000 individual patients and their families, in the comfort of patients' homes. Amedisys has two divisions, home health care and hospice, and employs more than 16,000 skilled clinicians across the country. The Company's state-of-the-art advanced chronic care management programs and leading-edge technology enables it to deliver quality care based upon the latest evidence-based best practices. Amedisys is a recognized innovator, being the first in the industry to equip its clinicians with point-of-care laptop technology and referring physicians with an internet portal that enables real-time coordination of patient care seamlessly. Amedisys also has the industry's first-ever nationwide Care Transitions program. Amedisys Care Transitions is designed to reduce unnecessary hospital readmissions through patient and caregiver health coaching and care coordination, which starts in the hospital and continues throughout completion of the patient's home health plan of care.

The Alaska Native Tribal Health Consortium is a non-profit health organization owned and managed by Alaska Native tribal governments and their regional health organizations. The Consortium was created in 1997 to provide statewide Native health services.

PhotoMedex manufactures and markets dermatological treatments for skin disorders such as acne, psoriasis, and vitiligo (loss of skin pigmentation). Other products include gels and creams intended to promote skin rejuvenation and hair growth. PhotoMedex also develops lasers and fiber-optic equipment for dermatological and surgical applications. Its FDA-approved XTRAC excimer laser system is used for the treatment of psoriasis and eczema. The company operates throughout the US and internationally serving dermatologists, cosmetic surgeons, and spas.

Vasomedical's noninvasive treatments for angina and congestive heart failure get patients' blood pumping. The company's main product is the EECP (enhanced external counterpulsation) system, which is also approved to treat coronary artery disease and cardiogenic shock. During the company's Medicare-covered treatments, cuffs attached to the patient's calves and thighs inflate and deflate in sync with the patient's heartbeat, increasing and decreasing aortic blood pressure. After about 35 treatments, patients may experience years of symptomatic relief. Vasomedical sells the system to hospitals, clinics, and other health care providers worldwide through a direct sales force and independent distributors.

TearLab (formerly OccuLogix) can read your tears. TearLab diagnostics company has developed and commercialized the TearLab Osmolarity System, a tear collection and analysis system for use at the point of care. The system detects biomarkers that indicate ophthalmic conditions; its first testing product aids in the diagnosis of dry eye disease (DED). After several failed attempts to develop medical therapies for ophthalmic ailments including glaucoma and macular degeneration,TearLab company became focused on diagnostic testing; it changed its name to TearLab in 2010.

Synovis Life Technologies believes no one should have to cow to life's illnesses, no matter how serious. The company makes biomaterials (using bovine heart lining) used in surgeries to reinforce tissue and prevent air and blood leaks. Its biggest seller is the Peri-Strip buttress which is used by surgeons to reinforce surgical staple lines, mainly in gastric bypass procedures. The Veritas line of devices are used to repair soft tissue during a range of reconstructive surgeries including abdominal wall, breast, and chest wall operations. Synovis manufactures products to repair and replace damaged tissue under its Tissue-Guard brand. It also makes devices that connect vessels or nerves in microsurgery procedures.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.